Biotecnika Most cancers Genomics Workshop Performed Efficiently
Bengaluru, Karnataka – BioTecNika is happy to announce the profitable completion of its “Profession-Centered 2-Day Most cancers Genomics Workshop: Unlock Alternatives in Genomic Analysis & Precision Drugs,” held on February eighth and ninth, 2025. The workshop supplied attendees with beneficial insights into the genetic foundation of most cancers and the most recent developments in genomic analysis and precision medication.
The net occasion noticed enthusiastic participation from college students, researchers, and professionals keen to boost their understanding of this quickly evolving area. Members gained in-depth data of most cancers biology and genomics, developed sensible expertise in most cancers genomics information evaluation, and explored the ideas and functions of precision medication and personalised most cancers therapies. The workshop additionally supplied beneficial profession growth steerage.
Key Takeaways for Attendees:
- Complete Understanding of Most cancers Genomics: Members gained a deep understanding of the genetic foundation of most cancers, together with key mutations, pathways, and mechanisms driving most cancers growth and development.
- Sensible Expertise in Information Evaluation: The workshop supplied hands-on coaching in analyzing most cancers genomics information, together with utilizing bioinformatics instruments and sources to interpret advanced datasets.
- Insights into Precision Drugs: Members discovered in regards to the ideas of precision medication and the way genomic data is used to personalize most cancers therapies, bettering remedy outcomes.
- Profession Growth in Most cancers Genomics: The workshop provided profession steerage, highlighting alternatives in analysis, diagnostics, drug growth, and different associated fields.
- Networking Alternatives: Attendees had the prospect to work together with main specialists in most cancers genomics and join with friends, fostering beneficial skilled relationships.
- Certificates of Participation: All attendees obtained a certificates of participation, recognizing their completion of the workshop and enhancing their skilled credentials.
- Up-to-Date Information: The workshop coated the most recent developments and rising developments in most cancers genomics, making certain contributors have been outfitted with probably the most present data.
Workshop Session Highlights:
Day 1: eighth February 2025: Genomic Strategies in Most cancers Analysis
Session I: Constructing the Foundations of Most cancers Genomics
Mrs. Tithi launched the basics of most cancers biology and genomics. The session coated the hallmarks of most cancers, forms of mutations, the function of miRNA, and key most cancers remedy developments. Animated movies helped clarify most cancers development and genetic mutations.
Session II: Genomic Strategies in Most cancers Analysis
Dr. Aggarwal explored the varied methods shaping most cancers analysis. Her session coated Subsequent-Technology Sequencing (NGS), RNA-Seq, Complete Exome Sequencing, CRISPR/Cas9, liquid biopsies and circulating tumor DNA (ctDNA), epigenomics methods like ChIP-Seq and ATAC-Seq, and microarray applied sciences for gene expression profiling. The working ideas of a number of of those methods have been demonstrated by way of animations and movies.
Session III: Most cancers Genomics Information Evaluation Pipeline
Mrs. Elamathi walked by way of the info evaluation pipeline, from sequencing to medical interpretation. She additionally demonstrated utilizing most cancers analysis instruments and databases like COSMIC, dbSNP, and GEO for gene evaluation, and gave hands-on steerage for utilizing these sources.
Day 2: ninth February 2025: Profession Growth in Most cancers Genomics
Session I: Precision Drugs in Oncology
Mrs. Divya targeted on genomics-driven precision medication in oncology, explaining FDA-approved focused therapies comparable to immune checkpoint inhibitors and small molecule therapies. The session included an animation on CAR-T-Cell remedy and most cancers immunotherapy.
Session II: Profession Growth in Most cancers Genomics
Dr. Sengupta supplied beneficial insights into profession growth inside most cancers genomics. He mentioned important expertise for fulfillment, varied profession paths in academia, trade (together with roles like genomics analyst, medical genomicist, and drug growth scientist), and medical settings. He additionally coated worldwide and nationwide institutes, figuring out internships, scholarships, analysis, and funding alternatives, in addition to the significance of networking and collaborations. Dr. Sengupta shared his personal experiences within the area.
Session III: Interactive Quiz/Exercise & Q&A
The workshop concluded with an attractive and interactive session, the place all school members participated. Attendees have been invited to problem their data with enjoyable actions, together with the “Spot-the-Most cancers-Genes Problem,” the place they recognized cancer-related genes, and a most cancers genomics-themed crossword puzzle. The session fostered a dynamic trade, with contributors actively participating in open discussions and a Q&A session, encouraging a deeper understanding of the subjects coated.
Professional Audio system:
- Dr. Savera Aggarwal: Professional in genomic methods and most cancers analysis.
Dr. Savera Aggarwal holds a PhD in Biomedical Science from the Institute of Liver and Biliary Science in Delhi. Over time, she has obtained vital recognition for her work. She was honored with the celebrated DST-Ladies Scientist A fellowship for 3 years, which allowed her to delve deeper into her analysis from 2018 to 2021.
Moreover, she had the privilege of being chosen as a Younger Investigator Awardee , the place she offered her findings on the worldwide APASL convention in Osaka, Japan, in 2021. Her dedication to advancing data in biomedical science is mirrored in her publications, with a number of articles featured in esteemed peer-reviewed journals, leading to an h-index of seven. Lately, she has launched into a brand new chapter in her profession journey as an Postdoctoral fellow at IIT-Hyderabad , the place she continued to pursue her ardour for analysis and contribute to the scientific neighborhood.
At present , she is pursuing her Postdoctoral Analysis in UTHealth in Texas, USA . Her area of curiosity is fatty liver induced Liver Most cancers and to develop diagnostic marker for early detection of Liver most cancers.
- Dr. Suman Sengupta: Scientist at immunitoAI Non-public Restricted, CCAMP, NCBS-TIFR Campus
Dr. Suman Sengupta holds a PhD in Most cancers Biology and Immunology from the College of Kalyani and the College of Calcutta. With a powerful tutorial basis, Dr. Sengupta has amassed three years of postdoctoral expertise at CSIR-IGIB, Delhi, and one 12 months at InStem (Institute for Stem Cell Science and Regenerative Drugs) in Bangalore.
Dr. Sengupta’s skilled journey features a function as a Analysis Scientist at Pandorum Applied sciences, Bangalore, for 3 years and 6 months. Throughout this time, Dr. Sengupta targeted on the event of 3D cell tradition fashions for drug screening platforms, in addition to the era of MSC-derived therapeutics aimed toward treating corneal wound therapeutic.
At present, Dr. Sengupta is working as a scientist at ImmunitoAI Non-public Restricted, the place they’ve spent three years creating AI-based platforms for antibody sequence design and figuring out therapeutic targets for most cancers and different ailments.
BioTecNika’s Dedication:
Biotecnika is a premier biotech training and profession steerage platform that gives coaching, job updates, and trade insights. By collaborations with main corporations and specialists, Biotecnika goals to bridge the talent hole within the biotech trade.
BioTecNika stays dedicated to offering high-quality instructional sources and coaching alternatives in cutting-edge areas of life sciences. We’re devoted to empowering people with the abilities and data they want to reach the quickly evolving world of biotechnology.
